A full study testing dexamethasone — a cheap, widely available steroid — as a treatment for COVID-19 found that the drug reduced mortality rates among patients on ventilators or who were receiving ...

Author(s)Kumar SK, Buadi FK, LaPlant B, et al. Phase 1/2 trial of ixazomib, cyclophosphamide, dexamethasone in patients with previously untreated symptomatic multiple myeloma. Blood Cancer J. 2018, ...

A dexamethasone-sparing regimen involving lenalidomide (Revlimid) and the anti-CD38 drug daratumumab (Darzalex) was safe and effective in older, frail patients with newly diagnosed multiple myeloma, ...

Reduction in the number of days seriously ill coronavirus patients are on mechanical ventilation can reduce respiratory complications. Dexamethasone treatment for coronavirus disease 2019 (COVID-19) ...

A paper published Friday in the New England Journal of Medicine suggests a low-cost steroid may be a valuable treatment for severe COVID-19, building upon encouraging preliminary findings from last ...

The drug is cheap and widely available, meaning it can be rolled out quickly to poorer communities hit by the disease. Researchers from Oxford University announced that the drug dexamethasone can cut ...

In a development that could dramatically shrink the death toll of the COVID-19 pandemic, British researchers have found that a cheap and readily available steroid prevented more than a third of the ...

Geographic and Ethnic Heterogeneity of Germline BRCA1 or BRCA2 Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial The trial enrolled 31 ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (WHNT) – Dexamethasone, a widely available ...

Intravitreal dexamethasone implants stabilized, but did not improve, vision for most patients with macular edema due to retinal vein occlusion (RVO). Intravitreal dexamethasone implants were found to ...

A dexamethasone-sparing regimen of daratumumab and lenalidomide was safe and effective in older, frail patients with newly diagnosed multiple myeloma. Among that select group of patients, ...